Prenatal cocaine exposure

Annals of the New York Academy of Sciences

Volumn 909, Issue , 2000, Pages 217-232

  Keller Jr , Richard W ^a   Snyder Keller, Abigail ^b  

^a ALBANY MEDICAL COLLEGE   (United States)

^b WADSWORTH CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

COCAINE; DOPAMINE; NEUROTRANSMITTER; NORADRENALIN; SEROTONIN;

AGING; ANIMAL EXPERIMENT; ANIMAL MODEL; BEHAVIOR DISORDER; BIRTH; BRAIN INFARCTION; CEPHALOMETRY; COCAINE DEPENDENCE; CONFERENCE PAPER; CONTROLLED STUDY; DISEASE COURSE; DISEASE PREDISPOSITION; DOPAMINE BRAIN LEVEL; DRUG METABOLISM; FEMALE; HUMAN; INTESTINE INFARCTION; IRRITABILITY; LOW BIRTH WEIGHT; MALE; MOTHER FETUS RELATIONSHIP; NEUROANATOMY; NEUROCHEMISTRY; NEWBORN; NONHUMAN; PREMATURITY; PRENATAL DRUG EXPOSURE; RAT; RESPIRATORY DISTRESS; SEIZURE SUSCEPTIBILITY; SEROTONIN BRAIN LEVEL;

ANIMALIA;

EID: 0033942920     PISSN: 00778923     EISSN: None     Source Type: Book Series    
DOI: 10.1111/j.1749-6632.2000.tb06684.x     Document Type: Conference Paper

References (47)

1. 1. PRICHARD, J.A. 1955. Plasma cholinesterase activity in normal pregnancy and in eclamptogenic toxemia. South Am. J. Obstet. Gynecol. 70: 1083.
2. 2. WILSON, J.G. 1973. In Environment and Birth Defects. Academic Press. New York, pp. 227-284.
3. 3. BROWN, W.U., G.C. BELL & M. ALPER. 1976. Acidosis, local anesthetics and newborn. Obstet. Gynecol. 48: 27-30.
4. 4. SHAH, N.S., D.A. MAY & J.D. YATES. 1980. Disposition of levo-[H]-cocaine in pregnant and non pregnant mice. Toxicol. Appl. Pharmacol. 53: 279-284.
5. 5. SPEAR, L.P., N.A. FRAMBES & C.L. KIRSTEIN. 1989. Fetal and maternal brain and plasma levels of cocaine and benzoylecgonine following chronic subcutaneous administration of cocaine during gestation in rats. Psychopharmacology 97: 427-431.
6. 6. WOODS, J.R., M.A. PLESSINGER & K.E. CLARK. 1987. Effects of cocaine on uterine blood flow and fetal oxygenation. JAMA 257: 957-961.
7. 7. CHASNOFF, I.J., J. BURNS, S.H. SCHNOLL & K.A. BURNS. 1985. Cocaine use in pregnancy. N. Engl. J. Med. 313: 666-669.
8. 8. CHASNOFF, I.J. 1988. The multiple deficits of prenatal drug abuse. Science Focus (N.Y. Acad. Sci.) Fall: 1-11.
9. 9. BRAUDE, M.C., H.H. SZETO, C.M. KUHN, L. BERO, D. IGNAR, E. FIELD, S. LURIE, I.J. CHASNOFF, J.H. MENDELSON, B. ZUCKERMAN, et al. 1987. Perinatal effects of drugs of abuse. Fed.Proc. 46: 2446-2453.
10. 10. MITCHELL, M., R.E. SABBAGHA, L. KEITH, S. MACGREGOR, J.M. MOTA & J. MINOQUE 1988. Ultrasonic growth parameters in fetuses of mothers with primary addiction to cocaine. Am. J. Obstet. Gynecol. 159: 1104-1109.
11. 11. BINGOL, N., M. FUCHS, V. DIAZ, R.K. STONE & D.S. GROMISCH. 1987. Teratogenicity of cocaine in humans. J. Pediatr. 110: 93-96.
12. 12. EYLER, F.D., M. BEHNKE, M. CONLON, N.S. WOODS & K. WOBIE. 1998. Birth outcome from a prospective, matched study of prenatal crack/cocaine use: II. Interactive and dose effects on neurobehavioral assessment. Pediatrics 101: 237-241.
13. 13. EYLER, F.D., M. BEHNKE, M. CONLON, N.S. WOODS & K. WOBIE. 1998. Birth outcome from a prospective, matched study of prenatal crack/cocaine use: 1. Interactive and dose effects on health and growth. Pediatrics 101: 229-237.
14. 14. CHASNOFF, I.J. & D.R. GRIFFITH. 1989. Cocaine: clinical studies of pregnancy and the newborn. Ann. N.Y. Acad. Sci. 562: 260-266.
15. 15. KELLER, R.W., JR., I.M. MAISONNEUVE, D.M. NUCCIO, J.N. CARLSON & S.D. GLICK. 1994. Effects of prenatal cocaine exposure on the nigrostriatal dopamine system: an in vivo microdialysis study in the rat. Brain Res. 634: 266-274.
16. 16. KELLER, R.W., JR., R. LEFEVRE, J. RAUCCI, J.N. CARLSON & S.D. GLICK. 1996. Enhanced cocaine self-administration in adult rats prenatally exposed to cocaine. Neurosci. Lett. 205: 153-156.
17. 17. KELLER, R.W., JR., K.S. JOHNSON, A.M. SNYDER-KELLER, J.N. CARLSON & S.D. GLICK. 1996. Effects of prenatal cocaine exposure on the mesocorticolimbic dopamine system: an in vivo microdialysis study in the rat. Brain Res. 742: 71-79.
18. 18. SNYDER-KELLER, A. & R.W. KELLER, JR. 1998. Stimulant-mediated c-fos induction in striatum as a function of age, sex, and prenatal cocaine exposure. Brain Res. 794: 88-95.
19. 19. SNYDER-KELLER, A. & R.W. KELLER, JR. 1998. Prenatal cocaine exposure increases susceptibility to drug-induced seizures. c-fos induction and brain cocaine levels. Ann. N. Y. Acad. Sci. 846: 419-422.
20. 20. SNYDER-KELLER, A.M. & R.W. KELLER, JR. 1995. Prenatal cocaine alters later sensitivity to cocaine-induced seizures. Neurosci. Lett. 191: 149-152.
21. 21. SNYDER-KELLER, A.M. & R.W. KELLER, JR. 1993. Prenatal cocaine increases striatal serotonin innervation without altering the patch/matrix organization of intrinsic cell types. Dev. Brain Res. 74: 261-267.
22. 22. SNYDER-KELLER, A., C. SAM & R.W. KELLER, JR. 1999. Enhanced susceptibility to cocaine-and pentylenetetrazol-induced seizures in prenatally cocaine-treated rats. Neurotoxicol. Teratol. In press.
23. 23. KELLER, R.W., JR., M.T. CHEN, R.M. PETERSON & A. SNYDER-KELLER. 1999. Prenatal cocaine exposure alters subsequent cocaine levels in the brains of rat pups as monitored by in vivo microdialysis. Brain Res. (reviewed and resubmitted).
24. 24. ZIMMERBERG, B. & M.S. GRAY. 1992. The effects of cocaine on maternal behaviors in the rat. Physiol. Behav. 52: 379-384.
25. 25. SILVERSTEIN, F. & M.V. JOHNSTON. 1984. Effects of hypoxia-ischemia on monoamine metabolism in the immature brain. Ann. Neurol. 15: 342-347.
26. 3H]-dopamine in rat brain tissue slices. Biochem. Pharmacol. 24: 847-852.
27. 27. ROSS, S.B. & A.L. RENYI. 1967. Inhibition of the uptake of tritiated catecholamines by antidepressants and related agents. Eur. J. Pharmacol. 2: 181-186.
28. 28. KOE, B.K. 1976. Molecular geometry of inhibitors of the uptake of catecholamines and serotonin in synaptosomal preparations of rat brain. J. Pharmacol. Exp. Ther. 199: 649-661.
29. 29. RANDRUP, A. & C. BRAESTRUP. 1977. Uptake inhibition of biogenic amines by newer antidepressant drugs: Relevance to the dopamine hypothesis of depression. Psychopharmacol. 53: 309-314.
30. 30. REITH, M.E.A., B.E. MEISLER, H. SERSHEN & A. LAJTHA. 1986. Structural requirements for cocaine congeners to interact with dopamine and serotonin uptake sites in mouse brain and to induce stereotyped behavior. Biochem. Pharmacol. 35: 1123-1129.
31. 31. ABERCROMBIE, E.D., K.A. KEEFE, D.S. DIFRISCHIA & M.J. ZIGMOND. 1989. Differential effect of stress on in vivo dopamine release in striatum, nucleus accumbens, and medial frontal cortex. J. Neurochem. 52: 1655-1658.
32. 32. NICOLAYSEN, L.C., H.-T. PAN & J.B. JUSTICE, JR. 1988. Extracellular cocaine and dopamine concentrations are linearly related in rat striatum. Brain Res. 456: 317-323.
33. 33. GIUSTINO, A., V. CUOMO & C.A. MARSDEN. 1998. Maternal cocaine exposure alters mesolimbic dopaminergic function in rat offspring. Eur. J. Pharmacol. 345: 175-180.
34. 34. REN, J.O., R.C. JONES, E.S. LO, M.A. SCHWARZSCHILD & B.E. KOSOFSKY. 1999. Attenuated cocaine-induced striatal dopamine release in adult mice exposed to cocaine in utero: an HPLC microdialysis study. Soc. Neurosci. Abstr. 25: 2078.
35. 35. GLICK, S.D., J. RAUCCI, S. WANG, R.W. KELLER, JR. & J.N. CARLSON. 1994. Neurochemical predisposition to self-administer cocaine in rats: individual differences in dopamine and its metabolites. Brain Res. 653: 148-154.
36. 36. WEEKS, J.R. 1972. Long-term intravenous infusion. In Methods in Psychobiology. R.D. Meyers, Ed. New York. Academic Press. 155-168.
37. 37. GLICK, S.D., P.A. HINDS & J.N. CARLSON. 1987. Food deprivation and stimulant self-administration in rats: differences between cocaine and d-amphetamine. Psychopharmacol. 91: 372-374.
38. 38. ROBERTS, D.C.S. & G. VICKERS. 1984. Atypical neuroleptics increase self-administration of cocaine: an evaluation of a behavioral screen for antipsychotic activity. Pharmacol. Biochem. Behav. 82: 135-139.
39. 39. SPEAR, L.P. 1993. Missing pieces of the puzzle complicate conclusions about cocaine's neurobehavioral toxicity in clinical populations. Neurotoxicol. Teratol. 15: 307-309.
40. 40. AKBARI, H.M., H.K. KRAMER, P.M. WHITAKER-AZMITIA, L.P. SPEAR & E.C. AZMITIA. 1992. Prenatal cocaine exposure disrupts the development of the serotonergic system. Brain Res. 572: 57-63.
41. 41. PERIS, J., M. COLEMAN-HARDEE & W.J. MILLARD. 1992. Cocaine in utero enhances the behavioral response to cocaine in adult rats. Pharmacol. Biochem. Behav. 42: 509-515.
42. 42. CHASNOFF, I.J. 1992. Cocaine, pregnancy, and the growing child. Curr. Probl. Pediatr. 22: 302-321.
43. 43. VOLPE, J.J. 1992. Effect of cocaine use on the fetus. N. Engl. J. Med. 327: 399-407.
44. 44. CHASNOFF, I.J., D.R. GRIFFITH, C. FREIER & J. MURRAY. 1992. Cocaine/polydrug use in pregnancy: two-year follow-up. Pediatrics 89: 284-289.
45. 45. AZUMA, S.D. & I.J. CHASNOFF. 1993. Outcome of children prenatally exposed to cocaine and other drugs: A path analysis of three-year data. Pediatrics 92: 396-402.
46. 46. COLES, C.D. 1993. Saying "Goodbye" to the "Crack Baby." Neurotoxicol.Teratol. 15: 290-292.
47. 47. HUTCHINGS, D.E. 1993. The puzzle of cocaine's effects following maternal use during pregnancy: Are there reconcilable differences? Neurotoxicol.Teratol. 15: 281-286.